Cargando…

The CCR5-Delta32 Genetic Polymorphism and HIV-1 Infection Susceptibility: a Meta-analysis

The CC chemokine receptor 5 (CCR5) is a chemokine receptor which is widely expressed in several immune cells involved in the inflammatory responses. Previous published studies revealed the relation of the CCR5 gene (CCR5-delta32) with the risk of HIV-1 infection, but the results are debatable and in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Jun, Wang, Dan, Wang, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2018
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6227735/ https://www.ncbi.nlm.nih.gov/pubmed/30426084 http://dx.doi.org/10.1515/med-2018-0062

Ejemplares similares

The global distribution of CCR5 delta 32 polymorphism: role in HIV-1 protection
por: Gupta, Anuroopa, et al.
Publicado: (2012)

Prevalence of CCR5delta32 in Northeastern Iran
por: Tajbakhsh, Amir, et al.
Publicado: (2019)

The association between CCR5 Δ32 polymorphism and susceptibility to breast cancer
por: Li, Junlong, et al.
Publicado: (2017)

Effect of CCR5-Δ32 Heterozygosity on HIV-1 Susceptibility: A Meta-Analysis
por: Liu, SiJie, et al.
Publicado: (2012)

Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3’A genetic polymorphisms in HIV-1 infected and uninfected patients in the West Region of Cameroon
por: Nkenfou, Céline Nguefeu, et al.
Publicado: (2013)

Coregulation of HIV-1 dependency factors in individuals heterozygous to the CCR5-delta32 deletion
por: Hütter, Gero, et al.
Publicado: (2013)

Clinical Significance of the CCR5delta32 Allele in Hepatitis C
por: Morard, Isabelle, et al.
Publicado: (2014)

HEK293T Cells Are Heterozygous for CCR5 Delta 32 Mutation
por: Qi, Chunxia, et al.
Publicado: (2016)

Prevalence of CCR5 Delta 32 Genetic Variant in the Turkmen Population of Golestan Province, Northeast of Iran
por: Norasi, Elmira, et al.
Publicado: (2023)

Distribution of the CCR5delta32 allele (gene variant CCR5) in Rondônia, Western Amazonian region, Brazil
por: de Farias, Josileide Duarte, et al.
Publicado: (2012)

The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations
por: Zare-Bidaki, Mohammad, et al.
Publicado: (2015)

Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis
por: Lindner, Ewald, et al.
Publicado: (2007)

Association between the CCR5Δ32 polymorphism and preeclampsia
por: Paula Telini, Bianca de, et al.
Publicado: (2014)

Polymorphisms in CCR5Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran
por: Heydarifard, Zahra, et al.
Publicado: (2017)

Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases
por: Ellwanger, Joel Henrique, et al.
Publicado: (2020)

Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer’s disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer’s disease)
por: Khorram Khorshid, Hamid Reza, et al.
Publicado: (2012)

Distribution of the mutated delta 32 allele of CCR5 co-receptor gene in Iranian population
por: Rahimi, Hamzeh, et al.
Publicado: (2014)

CCR2-64I and CCR5Δ32 Polymorphisms in Korean Patients with Myasthenia Gravis
por: Kim, Hyun Sook, et al.
Publicado: (2007)

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
por: Oh, Djin-Ye, et al.
Publicado: (2008)

Evaluating the Association between CCR5delta32 Polymorphism (rs333) and the Risk of Breast Cancer in a Cohort of Iranian Population
por: TAJBAKHSH, Amir, et al.
Publicado: (2021)

The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation
por: Hütter, Gero, et al.
Publicado: (2011)

The Geographic Spread of the CCR5 Δ32 HIV-Resistance Allele
por: Novembre, John, et al.
Publicado: (2005)

The CCR5Δ32 Polymorphism in Brazilian Patients with Sickle Cell Disease
por: Lopes, Mariana Pezzute, et al.
Publicado: (2014)

Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals
por: Trecarichi, Enrico M, et al.
Publicado: (2006)

The Case for Selection at CCR5-Δ32
por: Sabeti, Pardis C, et al.
Publicado: (2005)

Risk of HIV Infection and Lethality Are Decreased in CCR5del32 Heterozygotes: Focus Nosocomial Infection Study and Meta-analysis
por: Borinskaya, S.A., et al.
Publicado: (2012)

Genetic diversity and prevalence of CCR2-CCR5 gene polymorphisms in the Omani population
por: Al-Mahruqi, Samira H., et al.
Publicado: (2014)

Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands
por: Anitha, Anju Krishnan, et al.
Publicado: (2022)

Could FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequencies?
por: Faure, Eric
Publicado: (2008)

Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction
por: Le, Anh Q., et al.
Publicado: (2015)

Effect of TNF-α genetic variants and CCR5Δ32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards
por: Veloso, Sergi, et al.
Publicado: (2010)

CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation
por: Panda, Aditya K., et al.
Publicado: (2020)

CCR5-Δ32 polymorphism: a possible protective factor for post-stroke depressive symptoms
por: Tene, Oren, et al.
Publicado: (2021)

CCR5-Δ32 is deleterious in the homozygous state in humans
por: Wei, Xinzhu, et al.
Publicado: (2019)

Predominance of the heterozygous CCR5 delta‐24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface
por: Arendt, Vic, et al.
Publicado: (2019)

Association of the CCR5Δ32 variant with juvenile idiopathic arthritis in a meta-analysis
por: Reinards, THCM, et al.
Publicado: (2011)

Role of the CASP-9 Ex5+32 G>A polymorphism in susceptibility to cancer: A meta-analysis
por: YAN, SHI, et al.
Publicado: (2013)

Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients
por: Yilmaz, Abdulkerim, et al.
Publicado: (2014)

In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation
por: Jensen, Björn-Erik Ole, et al.
Publicado: (2023)

Risk of All-Cause Mortality in HIV Infected Patients Is Associated with Clinical, Immunologic Predictors and the CCR5 Δ32 Deletion
por: Parczewski, Milosz, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vujdpnenl98c5pmat85q0e1gr9